Seres Therapeutics, Inc. Shareholders' Equity
Seres Therapeutics, Inc. (MCRB) had Shareholders' Equity of $34.53 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $34.53M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $26.50M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $44.22M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $43.70M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $34.53M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $26.50M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $44.22M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $43.70M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $32.95M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $50.47M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $13.78M 10-Q · filed 2026-08-05 | |
| 2024-09-30 | $23.92M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$87.07M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | -$59.74M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | -$44.86M 10-K · filed 2026-03-12 | |
| 2023-09-30 | -$15.12M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $22.61M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | -$47.87M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $10.78M 10-K · filed 2026-03-12 | |
| 2022-09-30 | $67.58M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $23.06M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $80.96M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $131.51M 10-K · filed 2025-03-13 | |
| 2021-09-30 | $175.74M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $101.07M 10-Q · filed 2022-11-02 | |
| 2021-03-31 | $143.71M 10-Q · filed 2022-11-02 | |
| 2020-12-31 | $174.75M 10-K · filed 2024-03-05 | |
| 2020-09-30 | $188.05M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$65.58M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | -$61.65M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | -$48.32M 10-K · filed 2023-03-07 | |
| 2019-09-30 | -$32.22M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | -$17.97M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | -$69.83M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | -$48.05M 10-K · filed 2022-03-01 | |
| 2018-09-30 | -$30.57M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | -$13.25M 10-Q · filed 2019-11-05 | -$13.26M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $10.03M 10-Q · filed 2019-11-05 | $10.03M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $60.70M 10-K · filed 2021-03-02 | |
| 2017-09-30 | $85.51M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $87.93M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $111.45M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $132.63M 10-K · filed 2020-03-02 | |
| 2016-09-30 | $154.00M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $167.40M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $189.83M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $205.39M 10-K · filed 2019-03-06 | |
| 2015-09-30 | $222.20M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $94.91M 10-Q · filed 2015-08-10 | |
| 2014-12-31 | -$26.72M 10-K · filed 2018-03-08 | |
| 2013-12-31 | -$11.12M 10-K · filed 2017-03-16 | |
| 2012-12-31 | -$4.35M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |